Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

8174 items · filings · clear filters

  • SEC EDGAR•filings
    8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    Automated noteAccendra Health Inc. filed an 8-K reporting director and officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Ispire Technology Inc. (0001948455) (Filer)

    Automated noteIspire Technology Inc. filed a Form 8-K on September 17, 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Global Net Lease, Inc. (0001526113) (Filer)

    Automated noteGlobal Net Lease, Inc. filed a Form 8-K on September 17, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - YETI Holdings, Inc. (0001670592) (Filer)

    Automated noteYeti Holdings, Inc. filed a Form 8-K on September 17, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer)

    Automated noteNeonC Technologies Holdings, Inc. filed a Form 8-K on September 17, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Cenntro Inc. (0001707919) (Filer)

    Automated noteCenntro Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Alaunos Therapeutics, Inc. (0001107421) (Filer)

    Automated noteAlaunos Therapeutics, Inc. filed an 8-K reporting material modifications to security holders' rights and amendments to its articles of incorporation or bylaws, including a change to its fiscal year.

  • SEC EDGAR•filings
    8-K - Salesforce, Inc. (0001108524) (Filer)

    Automated noteSalesforce, Inc. filed a Form 8-K on September 17, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits as required under Items 7.01 and 9.01.

  • SEC EDGAR•filings
    8-K - BCB BANCORP INC (0001228454) (Filer)

    Automated noteBCB Bancorp Inc. filed a Form 8-K with the SEC on September 17, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - D-Wave Quantum Inc. (0001907982) (Filer)

    Automated noteD-Wave Quantum Inc. filed a Form 8-K on September 17, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BEACON TOPCO, INC. (0002094256) (Filer)

    Automated noteBeacon Topco, Inc. filed an 8-K reporting material modifications to security holders’ rights, amendments to its articles of incorporation and bylaws, including a change in fiscal year, and providing related financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - DUOS TECHNOLOGIES GROUP, INC. (0001396536) (Filer)

    Automated noteDuos Technologies Group filed a Form 8-K on September 17, 2026, reporting departures, elections, appointments and compensatory arrangements of certain officers, and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - NEWS CORP (0001564708) (Filer)

    Automated noteNews Corp filed a Form 8-K on September 17, 2026 (Accession No. 0001564708-26-000203), reporting Item 8.01 Other Events and providing Item 9.01 Financial Statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Mechanics Bancorp (0001518715) (Filer)

    Automated noteMechanics Bancorp filed a Form 8-K on September 17, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Beta Bionics, Inc. (0001674632) (Filer)

    Automated noteBeta Bionics, Inc. filed a Form 8-K with the SEC on September 17, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)

    Automated noteSonoma Pharmaceuticals, Inc. filed a Form 8-K indicating that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGAR•filings
    8-K - IMPACT BIOMEDICAL INC. (0001834105) (Filer)

    Automated noteImpact Biomedical Inc. filed a Form 8-K on September 17, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - HEARTLAND EXPRESS INC (0000799233) (Filer)

    Automated noteHeartland Express Inc. filed a Form 8-K on September 17, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) (Accession No. 0000799233-26-000043, 149 KB).

  • SEC EDGAR•filings
    8-K - Nordicus Partners Corp (0001011060) (Filer)

    Automated noteNordicus Partners Corp filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K/A - Brand Engagement Network Inc. (0001838163) (Filer)

    Automated noteBrand Engagement Network Inc. filed a Form 8-K amendment on September 17, 2026, providing Item 9.01 financial statements and exhibits (accession 0001493152-26-042965, 829 KB).

  • SEC EDGAR•filings
    8-K - Ernexa Therapeutics Inc. (0000748592) (Filer)

    Automated noteErnexa Therapeutics Inc. filed a Form 8-K on September 16 2026 (Accession No. 0001493152-26-042963), containing a Regulation FD disclosure and the company's financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - FG Nexus Inc. (0001591890) (Filer)

    Automated noteFG Nexus Inc. filed a Form 8-K on September 16, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - Aperture AC (0002093524) (Filer)

    Automated noteAperture AC filed a Form 8-K on September 16 2026, disclosing entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Apollo Commercial Real Estate Finance, Inc. (0001467760) (Filer)

    Automated noteApollo Commercial Real Estate Finance, Inc. filed a Form 8-K with the SEC on September 16 2026 (Accession No. 0001193125-26-393256), reporting an Item 8.01 “Other Events” disclosure.

  • SEC EDGAR•filings
    8-K - Tenon Medical, Inc. (0001560293) (Filer)

    Automated noteTenon Medical, Inc. filed an 8-K on September 16, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CID Holdco, Inc. (0002033770) (Filer)

    Automated noteCID Holdco, Inc. filed a Form 8-K on September 16, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BATTALION OIL CORP (0001282648) (Filer)

    Automated noteBattalion Oil Corp filed a Form 8-K on September 16, 2026, disclosing a notice of delisting or failure to meet a continued listing rule and indicating a transfer of its listing.

  • SEC EDGAR•filings
    8-K - ESSENTIAL PROPERTIES REALTY TRUST, INC. (0001728951) (Filer)

    Automated noteEssential Properties Realty Trust filed an 8-K reporting entry into and termination of material definitive agreements, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Matinas BioPharma Holdings, Inc. (0001582554) (Filer)

    Automated noteMatinas BioPharma Holdings, Inc. filed a Form 8-K with the SEC on September 16, 2026, reporting an Item 8.01 “Other Events” disclosure.

  • SEC EDGAR•filings
    8-K - Clene Inc. (0001822791) (Filer)

    Automated noteClene Inc. filed a Form 8-K on September 16, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.